Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...

The 2024 Interdisciplinary Biomedical Research Symposium was held Saturday, Nov. 16, at A.T. Still University in ...

Communicating research through presentations and publications is an important part ... Several undergraduate research programs and academic units also have symposiums/poster sessions throughout the ...

TruSight Oncology portfolio enables clinical research and in-vitro diagnostic CGP solutions ...

Illumina (ILMN) will release TruSight Oncology 500 v2, a new version of its flagship cancer research assay to enable comprehensive genomic ...

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-β) Agonist, was Well-tolerated with Significant Reductions in ...

Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patients ...

Eradivir , a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads ...

NKTR-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions - SAN FRANCISCO, Nov. 18, 2024 ...

The firm's co-founder and director on the success of his Create More podcast, the importance of having fun and why it is ...

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.